WallStreetZenWallStreetZen

NYSE: TAK
Takeda Pharmaceutical Co Ltd Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their TAK stock forecasts and price targets.

Forecast return on equity

Is TAK forecast to generate an efficient return?

Forecast return on assets

Is TAK forecast to generate an efficient return on assets?

TAK revenue forecast

What is TAK's revenue in the next 3 years based on estimates from 2 analysts?
Avg 1 year Forecast
$27.0B-8.19%
Avg 2 year Forecast
$27.5B-6.41%
Avg 3 year Forecast
$28.1B-4.45%
TAK's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

TAK revenue growth forecast

How is TAK forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?
Company
-0.36%
Industry
8.82%
Market
10.3%
TAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
TAK's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

TAK vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
TAK$13.18N/AN/A
HLN$8.06$9.50+17.87%Strong Buy
TEVA$13.23$14.43+9.06%Strong Buy
ZTS$149.77$226.20+51.03%Strong Buy
VTRS$11.32$11.00-2.83%Sell
View Top Pharmaceutical Stocks

Takeda Pharmaceutical Co Stock Forecast FAQ

What is TAK's revenue growth forecast for 2025-2027?

(NYSE: TAK) Takeda Pharmaceutical Co's forecast annual revenue growth rate of -0.36% is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 8.82%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.3%.

Takeda Pharmaceutical Co's revenue in 2024 is $28,380,183,798.On average, 2 Wall Street analysts forecast TAK's revenue for 2025 to be $42,350,202,337,090, with the lowest TAK revenue forecast at $41,766,341,692,028, and the highest TAK revenue forecast at $42,934,062,982,151. On average, 2 Wall Street analysts forecast TAK's revenue for 2026 to be $43,169,281,263,227, with the lowest TAK revenue forecast at $42,701,723,644,186, and the highest TAK revenue forecast at $43,636,838,882,268.

In 2027, TAK is forecast to generate $44,075,473,713,170 in revenue, with the lowest revenue forecast at $44,075,473,713,170 and the highest revenue forecast at $44,075,473,713,170.

If you're new to stock investing, here's how to buy Takeda Pharmaceutical Co stock.

What is TAK's forecast return on assets (ROA) for 2025-2027?

(NYSE: TAK) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of N/A.

What is TAK's forecast return on equity (ROE) for 2025-2027?

(NYSE: TAK) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.